The DOI matches its Crossref record; 197 of the 197 references it cites were found in a registry or an index.
Liquid biopsy in breast cancer: A comprehensive review
Abstract
Breast cancer is the most common cancer among women worldwide. Due to its complexity in nature, effective breast cancer treatment can encounter many challenges. Traditional methods of cancer detection such as tissue biopsy are not comprehensive enough to capture the entire genomic landscape of breast tumors. However, with the introduction of novel techniques, the application of liquid biopsy has been enhanced, enabling the improvement of various aspects of breast cancer management including early diagnosis and screening, prediction of prognosis, early detection of relapse, serial sampling and efficient longitudinal monitoring of disease progress and response to treatment. Various components of tumor cells released into the blood circulation can be analyzed in liquid biopsy sampling, some of which include circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), cell‐free RNA, tumor‐educated platelets and exosomes. These components can be utilized for different purposes. As an example, ctDNA can be sequenced for genetic profiling of the tumors to enhance individualized treatment and longitudinal screening. CTC plasma count analysis or ctDNA detection after curative tumor resection surgery could facilitate early detection of minimal residual disease, aiding in the initiation of adjuvant therapy to prevent recurrence. Furthermore, CTC plasma count can be assessed to determine the stage and prognosis of breast cancer. In this review, we discuss the advantages and limitations of the various components of liquid biopsy used in breast cancer diagnosis and will expand on aspects that require further focus in future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Kowal, J., Arras, G., Colombo, M., Jouve, M., Morath, J. P., Primdal-Bengtson, B., Dingli, F., Loew, D., Tkach, M., & Théry, C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521230113 · Cited by 3,426
Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162
Cell-free nucleic acids as biomarkers in cancer patients
Schwarzenbach, H., Hoon, D. S. B., & Pantel, K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3066 · Cited by 2,891
Liquid biopsies come of age: Towards implementation of circulating tumour DNA
Wan, J. C. M., Massie, C., Garcia-Corbacho, J., Mouliere, F., Brenton, J. D., Caldas, C., Pacey, S., Baird, R., & Rosenfeld, N. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.7 · Cited by 2,809
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A. A., Wong, F., Mattox, A., et al. (2018) · Science · doi:10.1126/science.aar3247 · Cited by 2,783
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Costa-Silva, B., Aiello, N. M., Ocean, A. J., Singh, S., Zhang, H., Thakur, B. K., Becker, A., Hoshino, A., Mark, M. T., Molina, H., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3169 · Cited by 2,692
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., et al. (2013) · Science · doi:10.1126/science.1228522 · Cited by 2,476
Liquid Biopsies: Genotyping Circulating Tumor DNA
Diaz, L. A., & Bardelli, A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2011 · Cited by 2,210
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Dawson, S.-J., Tsui, D. W. Y., Murtaza, M., Biggs, H., Rueda, O. M., Chin, S.-F., Dunning, M. J., Gale, D., Forshew, T., Mahler-Araujo, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213261 · Cited by 2,207
Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D., & Knippers, R. (2001) · PubMed · Cited by 2,169
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Integrating liquid biopsies into the management of cancer
Siravegna, G., Marsoni, S., Siena, S., & Bardelli, A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.14 · Cited by 1,908
The biology and function of exosomes in cancer
Kalluri, R. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81135 · Cited by 1,849
Epithelial-Mesenchymal Transitions
Kang, Y., & Massagué, J. (2004) · Cell · doi:10.1016/j.cell.2004.07.011 · Cited by 1,525
Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin
Snyder, M. W., Kircher, M., Hill, A. J., Daza, R. M., & Shendure, J. (2016) · Cell · doi:10.1016/j.cell.2015.11.050 · Cited by 1,464
Tumor Self-Seeding by Circulating Cancer Cells
Kim, M.-Y., Oskarsson, T., Acharyya, S., Nguyen, D. X., Zhang, X. H.-F., Norton, L., & Massagué, J. (2009) · Cell · doi:10.1016/j.cell.2009.11.025 · Cited by 1,335
Forshew, T., Murtaza, M., Parkinson, C., Gale, D., Tsui, D. W. Y., Kaper, F., Dawson, S.-J., Piskorz, A. M., Jimenez-Linan, M., Bentley, D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003726 · Cited by 1,297
Detection and quantification of mutations in the plasma of patients with colorectal tumors
Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L. A., Goodman, S. N., David, K. A., Juhl, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507904102 · Cited by 1,188
Rapid Clearance of Fetal DNA from Maternal Plasma
Lo, Y. M. D., Zhang, J., Leung, T. N., Lau, T. K., Chang, A. M. Z., & Hjelm, N. M. (1999) · The American Journal of Human Genetics · doi:10.1086/302205 · Cited by 1,157
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Garcia-Murillas, I., Schiavon, G., Weigelt, B., Ng, C., Hrebien, S., Cutts, R. J., Cheang, M., Osin, P., Nerurkar, A., Kozarewa, I., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab0021 · Cited by 1,150
Direct detection of early-stage cancers using circulating tumor DNA
Phallen, J., Sausen, M., Adleff, V., Leal, A., Hruban, C., White, J., Anagnostou, V., Fiksel, J., Cristiano, S., Papp, E., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan2415 · Cited by 1,119
Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood
Fan, H. C., Blumenfeld, Y. J., Chitkara, U., Hudgins, L., & Quake, S. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808319105 · Cited by 1,114
Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus
Lo, Y. M. D., Chan, K. C. A., Sun, H., Chen, E. Z., Jiang, P., Lun, F. M. F., Zheng, Y. W., Leung, T. Y., Lau, T. K., Cantor, C. R., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001720 · Cited by 1,101
Jansson, M. D., & Lund, A. H. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.006 · Cited by 1,099
Exfoliation of membrane ecto-enzymes in the form of micro-vesicles
Trams, E. G., Lauter, C. J., Norman Salem, Jr., & Heine, U. (1981) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(81)90512-5 · Cited by 1,093
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Shah, S. P., Morin, R. D., Khattra, J., Prentice, L., Pugh, T., Burleigh, A., Delaney, A., Gelmon, K., Guliany, R., Senz, J., et al. (2009) · Nature · doi:10.1038/nature08489 · Cited by 1,069
Baccelli, I., Schneeweiss, A., Riethdorf, S., Stenzinger, A., Schillert, A., Vogel, V., Klein, C., Saini, M., Bäuerle, T., Wallwiener, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2576 · Cited by 1,047
Detection of ultra-rare mutations by next-generation sequencing
Schmitt, M. W., Kennedy, S. R., Salk, J. J., Fox, E. J., Hiatt, J. B., & Loeb, L. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208715109 · Cited by 1,047
Christiansen, J. J., & Rajasekaran, A. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0410 · Cited by 1,046
Lipids in exosomes: current knowledge and the way forward
Skotland, T., Sandvig, K., & Llorente, A. (2017) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.03.001 · Cited by 1,030
Hayes, D. F., Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Miller, M. C., Matera, J., Allard, W. J., Doyle, G. V., & Terstappen, L. W. W. M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2821 · Cited by 1,030
Circulating tumor cells (CTC) detection: Clinical impact and future directions
Paterlini-Brechot, P., & Benali, N. L. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.014 · Cited by 947
Chiu, R. W. K., Chan, K. C. A., Gao, Y., Lau, V. Y. M., Zheng, W., Leung, T. Y., Foo, C. H. F., Xie, B., Tsui, N. B. Y., Lun, F. M. F., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810641105 · Cited by 942
Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy
Lee, Y., EL Andaloussi, S., & Wood, M. J. A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds317 · Cited by 938
Best, M. G., Sol, N., Kooi, I., Tannous, J., Westerman, B. A., Rustenburg, F., Schellen, P., Verschueren, H., Post, E., Koster, J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.018 · Cited by 916
Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples
Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., et al. (1991) · Science · doi:10.1126/science.2024123 · Cited by 875
De Mattos-Arruda, L., Mayor, R., Ng, C. K. Y., Weigelt, B., Martínez-Ricarte, F., Torrejon, D., Oliveira, M., Arias, A., Raventos, C., Tang, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms9839 · Cited by 865
Bidard, F.-C., Peeters, D. J., Fehm, T., Nolé, F., Gisbert-Criado, R., Mavroudis, D., Grisanti, S., Generali, D., Garcia-Saenz, J. A., Stebbing, J., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70069-5 · Cited by 838
Subclonal diversification of primary breast cancer revealed by multiregion sequencing
Yates, L. R., Gerstung, M., Knappskog, S., Desmedt, C., Gundem, G., Van Loo, P., Aas, T., Alexandrov, L. B., Larsimont, D., Davies, H., et al. (2015) · Nature Medicine · doi:10.1038/nm.3886 · Cited by 816
Tumor-Derived Exosomes and Their Role in Cancer Progression
(2016) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2015.12.005 · Cited by 755
Miller, M. C., Doyle, G. V., & Terstappen, L. W. M. M. (2010) · Journal of Oncology · doi:10.1155/2010/617421 · Cited by 750
Biology of HER2 and Its Importance in Breast Cancer
Yarden, Y. (2001) · Oncology · doi:10.1159/000055396 · Cited by 737
Aktas, B., Tewes, M., Fehm, T., Hauch, S., Kimmig, R., & Kasimir-Bauer, S. (2009) · Breast Cancer Research · doi:10.1186/bcr2333 · Cited by 736
Gene expression profiling in breast cancer: classification, prognostication, and prediction
Reis-Filho, J. S., & Pusztai, L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61539-0 · Cited by 729
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
Haber, D. A., & Velculescu, V. E. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-1014 · Cited by 694
Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways
Eroles, P., Bosch, A., Alejandro Pérez-Fidalgo, J., & Lluch, A. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.11.005 · Cited by 624
Molecular analysis of circulating tumour cells—biology and biomarkers
Krebs, M. G., Metcalf, R. L., Carter, L., Brady, G., Blackhall, F. H., & Dive, C. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.253 · Cited by 622
Identification of tissue-specific cell death using methylation patterns of circulating DNA
Lehmann-Werman, R., Neiman, D., Zemmour, H., Moss, J., Magenheim, J., Vaknin-Dembinsky, A., Rubertsson, S., Nellgård, B., Blennow, K., Zetterberg, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519286113 · Cited by 610
Lui, Y. Y., Chik, K.-W., Chiu, R. W., Ho, C.-Y., Lam, C. W., & Lo, Y. D. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.3.421 · Cited by 578
Clinical management of breast cancer heterogeneity
Zardavas, D., Irrthum, A., Swanton, C., & Piccart, M. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.73 · Cited by 570
EpCAM Is Overexpressed in Breast Cancer and Is a Potential Target for Breast Cancer Gene Therapy
Osta, W. A., Chen, Y., Mikhitarian, K., Mitas, M., Salem, M., Hannun, Y. A., Cole, D. J., & Gillanders, W. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0754 · Cited by 563
Circulating cell free DNA: Preanalytical considerations
El Messaoudi, S., Rolet, F., Mouliere, F., & Thierry, A. R. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.05.022 · Cited by 560
Muenst, S., Schaerli, A. R., Gao, F., Däster, S., Trella, E., Droeser, R. A., Muraro, M. G., Zajac, P., Zanetti, R., Gillanders, W. E., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2988-5 · Cited by 558
Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
deVos, T., Tetzner, R., Model, F., Weiss, G., Schuster, M., Distler, J., Steiger, K. V., Grützmann, R., Pilarsky, C., Habermann, J. K., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.115808 · Cited by 522
Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
Leary, R. J., Kinde, I., Diehl, F., Schmidt, K., Clouser, C., Duncan, C., Antipova, A., Lee, C., McKernan, K., De La Vega, F. M., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000702 · Cited by 517
Taly, V., Pekin, D., Benhaim, L., Kotsopoulos, S. K., Le Corre, D., Li, X., Atochin, I., Link, D. R., Griffiths, A. D., Pallier, K., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.206359 · Cited by 492
Chan, K. A., Jiang, P., Zheng, Y. W., Liao, G. J., Sun, H., Wong, J., Siu, S. S. N., Chan, W. C., Chan, S. L., Chan, A. T., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.196014 · Cited by 488
Murtaza, M., Dawson, S.-J., Pogrebniak, K., Rueda, O. M., Provenzano, E., Grant, J., Chin, S.-F., Tsui, D. W. Y., Marass, F., Gale, D., et al. (2015) · Nature Communications · doi:10.1038/ncomms9760 · Cited by 483
Gene Expression Profiles and Molecular Markers To Predict Recurrence of Dukes' B Colon Cancer
Wang, Y., Jatkoe, T., Zhang, Y., Mutch, M. G., Talantov, D., Jiang, J., McLeod, H. L., & Atkins, D. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.186 · Cited by 460
Olsson, E., Winter, C., George, A., Chen, Y., Howlin, J., Tang, M. E., Dahlgren, M., Schulz, R., Grabau, D., van Westen, D., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404913 · Cited by 453
Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells
Lin, H. K., Zheng, S., Williams, A. J., Balic, M., Groshen, S., Scher, H. I., Fleisher, M., Stadler, W., Datar, R. H., Tai, Y.-C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1105 · Cited by 451
Inferring expressed genes by whole-genome sequencing of plasma DNA
Ulz, P., Thallinger, G. G., Auer, M., Graf, R., Kashofer, K., Jahn, S. W., Abete, L., Pristauz, G., Petru, E., Geigl, J. B., et al. (2016) · Nature Genetics · doi:10.1038/ng.3648 · Cited by 441
Estimates of the worldwide frequency of twelve major cancers.
Parkin, D. M., Stjernswärd, J., & Muir, C. S. (1984) · Europe PMC (PubMed Central) · Cited by 437
O’Leary, B., Hrebien, S., Morden, J. P., Beaney, M., Fribbens, C., Huang, X., Liu, Y., Bartlett, C. H., Koehler, M., Cristofanilli, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03215-x · Cited by 414
HER2 expression identifies dynamic functional states within circulating breast cancer cells
Jordan, N. V., Bardia, A., Wittner, B. S., Benes, C., Ligorio, M., Zheng, Y., Yu, M., Sundaresan, T. K., Licausi, J. A., Desai, R., et al. (2016) · Nature · doi:10.1038/nature19328 · Cited by 406
Cellular microparticles: what are they bad or good for?
Freyssinet, J.-M. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00309.x · Cited by 399
Blood platelets contain tumor-derived RNA biomarkers
Nilsson, R. J. A., Balaj, L., Hulleman, E., van Rijn, S., Pegtel, D. M., Walraven, M., Widmark, A., Gerritsen, W. R., Verheul, H. M., Vandertop, W. P., et al. (2011) · Blood · doi:10.1182/blood-2011-03-344408 · Cited by 399
Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
Beaver, J. A., Jelovac, D., Balukrishna, S., Cochran, R. L., Croessmann, S., Zabransky, D. J., Wong, H. Y., Valda Toro, P., Cidado, J., Blair, B. G., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2933 · Cited by 398
Giacona, M. B., Ruben, G. C., Iczkowski, K. A., Roos, T. B., Porter, D. M., & Sorenson, G. D. (1998) · Pancreas · doi:10.1097/00006676-199807000-00012 · Cited by 387
De Mattos-Arruda, L., Weigelt, B., Cortes, J., Won, H. H., Ng, C. K. Y., Nuciforo, P., Bidard, F.-C., Aura, C., Saura, C., Peg, V., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu239 · Cited by 386
Frequent expression of PD‐L1 on circulating breast cancer cells
Mazel, M., Jacot, W., Pantel, K., Bartkowiak, K., Topart, D., Cayrefourcq, L., Rossille, D., Maudelonde, T., Fest, T., & Alix-Panabières, C. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.05.009 · Cited by 374
Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID
Jabara, C. B., Jones, C. D., Roach, J., Anderson, J. A., & Swanstrom, R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110064108 · Cited by 365
Challenges in circulating tumor cell detection by the CellSearch system
Andree, K. C., van Dalum, G., & Terstappen, L. W. M. M. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2015.12.002 · Cited by 363
Thomas, R. K., Nickerson, E., Simons, J. F., Jänne, P. A., Tengs, T., Yuza, Y., Garraway, L. A., LaFramboise, T., Lee, J. C., Shah, K., et al. (2006) · Nature Medicine · doi:10.1038/nm1437 · Cited by 361
Detection of tumor messenger RNA in the serum of patients with malignant melanoma.
KOPRESKI, M. S., Benko, F. A., Kwak, L. W., & Gocke, C. D. (1999) · PubMed · Cited by 359
Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women
Jemal, A., Ward, E., & Thun, M. J. (2007) · Breast Cancer Research · doi:10.1186/bcr1672 · Cited by 351
Aga, M., Bentz, G. L., Raffa, S., Torrisi, M. R., Kondo, S., Wakisaka, N., Yoshizaki, T., Pagano, J. S., & Shackelford, J. (2014) · Oncogene · doi:10.1038/onc.2014.66 · Cited by 337
Gray, E. S., Rizos, H., Reid, A. L., Boyd, S. C., Pereira, M. R., Lo, J., Tembe, V., Freeman, J., Lee, J. H. J., Scolyer, R. A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5788 · Cited by 336
Umetani, N., Kim, J., Hiramatsu, S., Reber, H. A., Hines, O. J., Bilchik, A. J., & Hoon, D. S. B. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.068577 · Cited by 331
Molecular and Cellular Heterogeneity in Breast Cancer
Rivenbark, A. G., O’Connor, S. M., & Coleman, W. B. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.08.002 · Cited by 327
Kimura, H., Kasahara, K., Kawaishi, M., Kunitoh, H., Tamura, T., Holloway, B., & Nishio, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2324 · Cited by 323
Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment
Sun, X.-X., & Yu, Q. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.92 · Cited by 318
Platelets and Angiogenesis in Malignancy
(2004) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2004-822974 · Cited by 315
Chromosomal DNA fragmentation in apoptosis and necrosis induced by oxidative stress
Higuchi, Y. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00508-2 · Cited by 302
Treatment of Estrogen Receptor-Positive Breast Cancer
Lumachi, F., Brunello, A., Maruzzo, M., Basso, U., & Basso, S. (2013) · Current Medicinal Chemistry · doi:10.2174/092986713804999303 · Cited by 291
Tamoxifen Resistance in Breast Cancer
Chang, M.-S. (2012) · Biomolecules and Therapeutics · doi:10.4062/biomolther.2012.20.3.256 · Cited by 285
Hyun, K.-A., Koo, G.-B., Han, H., Sohn, J., Choi, W., Kim, S.-I., Jung, H.-I., & Kim, Y.-S. (2016) · Oncotarget · doi:10.18632/oncotarget.8250 · Cited by 274
Wong, S. Q., Li, J., Tan, A. Y.-C., Vedururu, R., Pang, J.-M. B., Do, H., Ellul, J., Doig, K., Bell, A., McArthur, G. A., et al. (2014) · BMC Medical Genomics · doi:10.1186/1755-8794-7-23 · Cited by 247
Detection of K‐ras gene mutation by liquid biopsy in patients with pancreatic cancer
Kinugasa, H., Nouso, K., Miyahara, K., Morimoto, Y., Dohi, C., Tsutsumi, K., Kato, H., Matsubara, T., Okada, H., & Yamamoto, K. (2015) · Cancer · doi:10.1002/cncr.29364 · Cited by 239
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
CRISTOFANILLI, M. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.03.016 · Cited by 230
Gasch, C., Bauernhofer, T., Pichler, M., Langer-Freitag, S., Reeh, M., Seifert, A. M., Mauermann, O., Izbicki, J. R., Pantel, K., & Riethdorf, S. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.188557 · Cited by 227
Circulating tumor cell clusters: What we know and what we expect (Review)
Hong, Y., Fang, F., & Zhang, Q. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3747 · Cited by 218
Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing
Amant, F., Verheecke, M., Wlodarska, I., Dehaspe, L., Brady, P., Brison, N., Van Den Bogaert, K., Dierickx, D., Vandecaveye, V., Tousseyn, T., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1883 · Cited by 217
Circulating Cell-Free DNA: An Up-Coming Molecular Marker in Exercise Physiology
Breitbach, S., Tug, S., & Simon, P. (2012) · Sports Medicine · doi:10.2165/11631380-000000000-00000 · Cited by 209
Do Circulating Tumor Cells, Exosomes, and Circulating Tumor Nucleic Acids Have Clinical Utility?
Gold, B., Cankovic, M., Furtado, L. V., Meier, F., & Gocke, C. D. (2015) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.02.001 · Cited by 205
Platelets and platelet-like particles mediate intercellular RNA transfer
Risitano, A., Beaulieu, L. M., Vitseva, O., & Freedman, J. E. (2012) · Blood · doi:10.1182/blood-2011-12-396440 · Cited by 205
Wang, P., Bahreini, A., Gyanchandani, R., Lucas, P. C., Hartmaier, R. J., Watters, R. J., Jonnalagadda, A. R., Trejo Bittar, H. E., Berg, A., Hamilton, R. L., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1534 · Cited by 202
Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
Board, R. E., Wardley, A. M., Dixon, J. M., Armstrong, A. C., Howell, S., Renshaw, L., Donald, E., Greystoke, A., Ranson, M., Hughes, A., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0747-9 · Cited by 201
Choi, J., Reich, C. F., & Pisetsky, D. S. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02130.x · Cited by 198
Get on the exosome bus with ALIX
Hurley, J. H., & Odorizzi, G. (2012) · Nature Cell Biology · doi:10.1038/ncb2530 · Cited by 196
Harouaka, R., Kang, Z., Zheng, S.-Y., & Cao, L. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.004 · Cited by 195
Precision Oncology: The Road Ahead
Senft, D., Leiserson, M. D. M., Ruppin, E., & Ronai, Z. A. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.08.003 · Cited by 195
Rodriguez-dorantes, M., Romero-Cordoba, S., Peralta-Zaragoza, O., Salido-Guadarrama, I., & Hidalgo-Miranda, A. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s61562 · Cited by 188
Prognostic and Predictive Biomarkers: Tools in Personalized Oncology
Nalejska, E., Mączyńska, E., & Lewandowska, M. A. (2014) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-013-0077-9 · Cited by 188
Molecular heterogeneity in breast cancer: State of the science and implications for patient care
Ellsworth, R. E., Blackburn, H. L., Shriver, C. D., Soon-Shiong, P., & Ellsworth, D. L. (2017) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2016.08.025 · Cited by 182
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy
Shaw, J. A., Page, K., Blighe, K., Hava, N., Guttery, D., Ward, B., Brown, J., Ruangpratheep, C., Stebbing, J., Payne, R., et al. (2012) · Genome Research · doi:10.1101/gr.123497.111 · Cited by 180
Exosome cancer diagnostic reaches market
Sheridan, C. (2016) · Nature Biotechnology · doi:10.1038/nbt0416-359 · Cited by 174
Reducing amplification artifacts in high multiplex amplicon sequencing by using molecular barcodes
Peng, Q., Satya, R. V., Lewis, M., Randad, P., & Wang, Y. (2015) · BMC Genomics · doi:10.1186/s12864-015-1806-8 · Cited by 173
Boulding, T., McCuaig, R., Tan, A., Hardy, K., Wu, F., Dunn, J., Kalimutho, M., Sutton, C. R., Forwood, J. K., Bert, A. G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-17913-x · Cited by 169
Mastoraki, S., Strati, A. D., Tzanikou, E., Chimonidou, M., Politaki, E., Voutsina, A., Psyrri, A. K., Georgoulias, V., & Lianidou, E. S. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1181 · Cited by 168
Pestrin, M., Salvianti, F., Galardi, F., De Luca, F., Turner, N., Malorni, L., Pazzagli, M., Di Leo, A., & Pinzani, P. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2014.12.001 · Cited by 166
The potential of liquid biopsies for the early detection of cancer
Heitzer, E., Perakis, S., Geigl, J. B., & Speicher, M. R. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0039-5 · Cited by 166
Guttery, D. S., Page, K., Hills, A., Woodley, L., Marchese, S. D., Rghebi, B., Hastings, R. K., Luo, J., Pringle, J. H., Stebbing, J., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.238717 · Cited by 164
Retrospective analysis of metastatic behaviour of breast cancer subtypes
Savci-Heijink, C. D., Halfwerk, H., Hooijer, G. K. J., Horlings, H. M., Wesseling, J., & van de Vijver, M. J. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3352-0 · Cited by 161
Madhavan, D., Wallwiener, M., Bents, K., Zucknick, M., Nees, J., Schott, S., Cuk, K., Riethdorf, S., Trumpp, A., Pantel, K., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2946-2 · Cited by 161
Rossi, G., Mu, Z., Rademaker, A. W., Austin, L. K., Strickland, K. S., Costa, R. L. B., Nagy, R. J., Zagonel, V., Taxter, T. J., Behdad, A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2092 · Cited by 161
Circulating tumor-derived DNA is shorter than somatic DNA in plasma
Mouliere, F., & Rosenfeld, N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501321112 · Cited by 160
Intratumor Heterogeneity in Breast Cancer
de Beça, F. F., & Polyák, K. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22909-6_7 · Cited by 160
Exosomes in Cancer Microenvironment and Beyond: have we Overlooked these Extracellular Messengers?
Ge, R., Tan, E., Sharghi-Namini, S., & Asada, H. H. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0110-2 · Cited by 159
Kowalik, A., Kowalewska, M., & Góźdź, S. S. (2017) · Translational research · doi:10.1016/j.trsl.2017.04.002 · Cited by 157
Madic, J., Kiialainen, A., Bidard, F., Birzele, F., Ramey, G., Leroy, Q., Frio, T. R., Vaucher, I., Raynal, V., Bernard, V., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29265 · Cited by 153
Apoptosis of circulating tumor cells in prostate cancer patients
Larson, C. J., Moreno, J. G., Pienta, K. J., Gross, S., Repollet, M., O'Hara, S. M., Russell, T. B., & Terstappen, L. W. M. M. (2004) · Cytometry Part A · doi:10.1002/cyto.a.20073 · Cited by 151
PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients
Oshiro, C., Kagara, N., Naoi, Y., Shimoda, M., Shimomura, A., Maruyama, N., Shimazu, K., Kim, S. J., & Noguchi, S. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3322-6 · Cited by 151
An evaluation of copy number variation detection tools for cancer using whole exome sequencing data
Zare, F., Dow, M. T., Monteleone, N. J., Hosny, A., & Nabavi, S. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1705-x · Cited by 149
Millner, L., Linder, M. W., & Valdes, R. (2013) · PubMed · Cited by 148
"Liquid biopsy"-ctDNA detection with great potential and challenges.
Ma, M., Zhu, H., Zhang, C., Sun, X., Gao, X., & Chen, G. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.09.29 · Cited by 144
Chae, Y. K., Davis, A. A., Jain, S., Santa-Maria, C. A., Flaum, L., Beaubier, N. T., Platanias, L. C., Gradishar, W. J., Giles, F. J., & Cristofanilli, M. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0061 · Cited by 144
CA 15–3: A Prognostic Marker in Breast Cancer
Duffy, M. J., Shering, S. G., Sherry, F., McDermott, E. W. M., & O’Higgins, N. J. (2000) · The International Journal of Biological Markers · doi:10.1177/172460080001500410 · Cited by 142
Ono, S., Lam, S., Nagahara, M., & Hoon, D. S. �. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4101890 · Cited by 140
Saliva Liquid Biopsy for Point-of-Care Applications
Aro, K. L. S., Fang, W., Wong, D. T., & Tu, M. K. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00077 · Cited by 140
Soysal, S. D., Muenst, S. E., Barbie, T. U., Fleming, T. P., Gao, F., Spizzo, G., Oertli, D., Viehl, C. T., Obermann, E. C., & Gillanders, W. E. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.80 · Cited by 137
Cell-free DNA as a diagnostic marker for cancer: current insights
Salvi, S., Gurioli, G., Giorgi, U. D., Conteduca, V., Tedaldi, G., Calistri, D., & Casadio, V. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s100901 · Cited by 137
van Ginkel, J. H., Huibers, M. M. H., van Es, R. J. J., de Bree, R., & Willems, S. M. (2017) · BMC Cancer · doi:10.1186/s12885-017-3424-0 · Cited by 136
Optimization of ferrofluids and protocols for the enrichment of breast tumor cells in blood
Liberti, P. A., Rao, C., & Terstappen, L. W. M. M. (2001) · Journal of Magnetism and Magnetic Materials · doi:10.1016/s0304-8853(00)01254-3 · Cited by 135
Cancer Progression Mediated by Horizontal Gene Transfer in an In Vivo Model
Trejo‐Becerril, C., Pérez‐Cárdenas, E., Taja‐Chayeb, L., Anker, P., Herrera‐Goepfert, R., Medina-Velázquez, L. A., Hidalgo‐Miranda, A., Pérez‐Montiel, D., Chávez-Blanco, A. D., Cruz, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052754 · Cited by 134
Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer
Swisher, E. M., Wollan, M., Mahtani, S. M., Willner, J. B., Garcia, R. L., Goff, B. A., & King, M. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.01.054 · Cited by 130
Discovery and validation of breast cancer subtypes
Kapp, A. V., Jeffrey, S. S., Langerød, A., Børresen‐Dale, A., Han, W., Noh, D., Bukholm, I. R., Nicolau, M. M., Brown, P. O., & Tibshirani, R. J. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-231 · Cited by 129
Chen, Y.-H., Hancock, B. A., Solzak, J. P., Brinza, D., Scafe, C., Miller, K. D., & Radovich, M. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0028-4 · Cited by 129
Hyun, K.-A., Kwon, K., Han, H., Kim, S. I., & Jung, H. (2012) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2012.07.021 · Cited by 126
Chen, K., Lou, F., Yang, F., Zhang, J., Ye, H., Chen, W., Guan, T., Zhao, M.-Y., Su, X.-X., Shi, R., et al. (2016) · Scientific Reports · doi:10.1038/srep31985 · Cited by 125
Aktas, B., Müller, V., Tewes, M., Zeitz, J., Kasimir‐Bauer, S., Loehberg, C. R., Rack, B. K., Schneeweiß, A., & Fehm, T. N. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.04.039 · Cited by 124
Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA
Chaudhuri, A. A., Binkley, M. S., Osmundson, E. C., Alizadeh, A. A., & Diehn, M. (2015) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2015.05.001 · Cited by 121
Speicher, M. R., & Pantel, K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2897 · Cited by 118
Li, H., Liu, J., Chen, J., Wang, H., Yang, L., Chen, F., Fan, S., Wang, J., Shao, B., Yin, D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03537-w · Cited by 113
Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring
Pérez-Callejo, D., Romero, A., Provencio, M., & Torrente, M. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.10.07 · Cited by 112
Differential Platelet Levels Affect Response to Taxane-Based Therapy in Ovarian Cancer
Bottsford-Miller, J. N., Choi, H. J., Dalton, H. J., Stone, R. L., Cho, M. S., Hämmerle, M., Nick, A. M., Pradeep, S., Zand, B., Previs, R. A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0870 · Cited by 111
Mouliere, F. C., & Thierry, A. R. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.688023 · Cited by 110
Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management
Vendrell, J. A., Mau‐Them, F. T., Béganton, B., Godreuil, S., Coopman, P. J., & Solassol, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020264 · Cited by 109
Isolation and Extraction of Circulating Tumor DNA from Patients with Small Cell Lung Cancer
Ruth E. Board, Williams, V. S., Knight, L., Shaw, J., Greystoke, A., Ranson, M., Dive, C., Blackhall, F. H., & Hughes, A. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.020 · Cited by 106
EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer
Schneck, H., Gierke, B., Uppenkamp, F., Behrens, B., Niederacher, D., Stoecklein, N. H., Templin, M. F., Pawlak, M., Fehm, T. N., Neubauer, H. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144535 · Cited by 106
Fate of Injected Deoxyribonucleic Acid in Mice
Tsumita, T., & Iwanaga, M. (1963) · Nature · doi:10.1038/1981088a0 · Cited by 104
Kidess, E., & Jeffrey, S. S. (2013) · Genome Medicine · doi:10.1186/gm474 · Cited by 104
Treatment-Induced Mutagenesis and Selective Pressures Sculpt Cancer EvolutionPreprint
Venkatesan, S., Swanton, C., Taylor, B. S., & Costello, J. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026617 · Cited by 99
Husain, H., Nykin, D., Bui, N. Q., Quan, D. L., Gomez, G. G., Woodward, B. D., Venkatapathy, S., Duttagupta, R., Fung, E. T., Lippman, S. M., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0436 · Cited by 97
Circulating nucleic acids in plasma or serum
Anker, P., Lyautey, J., Lederrey, C., & Stroun, M. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00666-0 · Cited by 95
MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers
Jackson, B. L., Grabowska, A. M., & Ratan, H. L. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-930 · Cited by 94
Selli, Ç., Dixon, J. M., & Sims, A. H. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0779-0 · Cited by 88
Chung, J., Pavlick, D. C., Hartmaier, R. J., Schrock, A. B., Young, L., Forcier, B., Ye, P., Levin, M. K., Goldberg, M. E., Burris, H. A., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx490 · Cited by 87
Nucleosome Positioning, Nucleosome Spacing and the Nucleosome Code
Clark, D. J. (2010) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/073911010010524945 · Cited by 84
Tug, S., Helmig, S., Weinmann‐Menke, J., Zahn, D., Kubiak, T., Schwarting, A., & Simon, P. D. (2014) · Cellular Immunology · doi:10.1016/j.cellimm.2014.08.002 · Cited by 80
Metastasis-promoting role of extravasated platelet activation in tumor
Miyashita, T., Tajima, H., Makino, I., Nakagawara, H., Kitagawa, H., Fushida, S., Harmon, J. W., & Ohta, T. (2014) · Journal of Surgical Research · doi:10.1016/j.jss.2014.07.037 · Cited by 80
DNA Mutations May Not Be the Cause of Cancer
Adjiri, A. (2017) · Oncology and Therapy · doi:10.1007/s40487-017-0047-1 · Cited by 76
Lee, Y. J., Yoon, K., Han, J., Kim, H. T., Yun, T., Lee, G. K., Kim, H. Y., & Lee, J. S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0400 · Cited by 70
Circulating DNA in the Blood of Gastric Cancer Patients
Kolesnikova, E. V., TAMKOVICH, S. N., Bryzgunova, O. E., Shelestyuk, P. I., Permyakova, V. I., Vlassov, V. V., Tuzikov, A. S., Laktionov, P. P., & RYKOVA, E. Y. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.009 · Cited by 66
Minimal residual disease and circulating tumor cells in breast cancer
Ignatiadis, M., & Reinholz, M. M. (2011) · Breast Cancer Research · doi:10.1186/bcr2906 · Cited by 63
Beije, N., Sieuwerts, A. M., Kraan, J., Van, N. M., Onstenk, W., Vitale, S. R., van der Vlugt‐Daane, M., Dirix, L. Y., Brouwer, A., Hamberg, P., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12147 · Cited by 62
Exosomes as diagnostic biomarkers in cancer
Kim, J., Kim, E., & Lee, M. (2018) · Molecular & Cellular Toxicology · doi:10.1007/s13273-018-0014-4 · Cited by 60
Bonechi, M., Galardi, F., Biagioni, C., Luca, F. D., Bergqvist, M., Neumüller, M., Guarducci, C., Boccalini, G., Gabellini, S., Migliaccio, I., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24700 · Cited by 55
Kırkızlar, E., Zimmermann, B. G., Constantin, T. P., Swenerton, R., Hoang, B., Wayham, N. P., Babiarz, J., Demko, Z., Pelham, R. J., Kareht, S., et al. (2015) · Translational Oncology · doi:10.1016/j.tranon.2015.08.004 · Cited by 53
Onstenk, W., Sieuwerts, A. M., Weekhout, M., Mostert, B., Reijm, E. A., van Deurzen, C. H. M., Vries, J. B., Peeters, D. J. E., Hamberg, P., Seynaeve, C., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.020 · Cited by 50
Fendt, L., Niederstätter, H., Huber, G. E., Zelger, B. G., Dünser, M., Seifarth, C., Röck, A. W., Schäfer, G., Klocker, H., & Parson, W. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1092-8 · Cited by 49
Emerging platforms using liquid biopsy to detect EGFR mutations in lung cancer
Lin, C., Huang, W.-L., Fang, W., Su, W., & Wong, D. T. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1094379 · Cited by 44
Lee, J. H., Jeong, H., Choi, J.-W., Oh, H. E., & Kim, Y. (2018) · Medicine · doi:10.1097/md.0000000000012862 · Cited by 43
Kruspe, S., Dickey, D. D., Urak, K. T., Blanco, G. N., Miller, M. J., Clark, K. C., Burghardt, E. L., Gutierrez, W. R., Phadke, S. D., Kamboj, S., et al. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.08.004 · Cited by 41
Shuga, J., Zeng, Y., Novak, R., Lan, Q., Tang, X., Rothman, N., Vermeulen, R. C. H., Li, L., Hubbard, A., Zhang, L., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt613 · Cited by 40
Microsatellite analysis of serum DNA in patients with head and neck cancer
Nawroz, H., Eisenberger, C. F., Yoo, G. H., Wu, L., Koch, W. M., Black, C., Ensley, J. F., Wei, W., & Sidransky, D. (2004) · International Journal of Cancer · doi:10.1002/ijc.20240 · Cited by 39
Nakauchi, C., Kagara, N., Shimazu, K., Shimomura, A., Naoi, Y., Shimoda, M., Kim, S. J., & Noguchi, S. (2016) · Clinical Breast Cancer · doi:10.1016/j.clbc.2016.05.004 · Cited by 39
Kallergi, G., Agelaki, S., Papadaki, M. A., Nasias, D., Matikas, A., Mavroudis, D., & Georgoulias, V. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0624-x · Cited by 37
Intratumoral Heterogeneity in Breast Cancer: A Comparison of Primary and Metastatic Breast Cancers
Shi, Y., Tsang, J. Y., Ni, Y., & Tse, G. M.-K. (2017) · The Oncologist · doi:10.1634/theoncologist.2016-0352 · Cited by 37
Sands, J. M., Li, Q., & Hornberger, J. C. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.05.014 · Cited by 34
Cell-free DNA detected by “liquid biopsy” as a potential prognostic biomarker in early breast cancer
Maltoni, R., Casadio, V., Ravaioli, S., Foca, F., Tumedei, M. M., Salvi, S., Martignano, F., Calistri, D., Rocca, A., Schirone, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15120 · Cited by 31
Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer
Hu, W., Yang, Y., Zhang, L., Yin, J., Huang, J., Huang, L., Gu, H., Jiang, G., & Fang, J. (2017) · Cancer Medicine · doi:10.1002/cam4.980 · Cited by 30
Selecting short DNA fragments in plasma improves detection of circulating tumour DNAPreprint
Mouliere, F. C., Piskorz, A., Chandrananda, D., Moore, E. K., Morris, J., Smith, C. G., Goranova, T., Heider, K., Mair, R. J., Supernat, A. M., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/134437 · Cited by 28
Shivapurkar, N., Vietsch, E. E., Carney, E., Isaacs, C. J., & Wellstein, A. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0169-y · Cited by 25
Kaisaki, P. J., Cutts, A., Popitsch, N. P., Camps, C., Pentony, M. M., Wilson, G. A., Page, S., Kaur, K., Vavoulis, D. V., Henderson, S. J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162809 · Cited by 21
Big Bang and context-driven collapse
Robertson‐Tessi, M., & Anderson, A. R. A. (2015) · Nature Genetics · doi:10.1038/ng.3231 · Cited by 20
Clery, E., Pisapia, P., Feliciano, S., Vigliar, E., Marano, A., Luca, C. D., Malapelle, U., Troncone, G., & Bellevicine, C. (2017) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2017-204370 · Cited by 18
Sun, D. S., Dalin, S., Hemann, M. T., Lauffenburger, D. A., & Zhao, B. (2016) · Scientific Reports · doi:10.1038/srep36198 · Cited by 17
Strauss, W. M., Carter, C., Simmons, J., Klem, E., Goodman, N., Vahidi, B., Romero, J., Masterman-Smith, M. D., O'Regan, R. M., Gogineni, K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8494 · Cited by 15
Gene Expression Profiling in Hereditary, BRCA1-linked Breast Cancer: Preliminary Report
Dudaladava, V., Jarząb, M., Stobiecka, E., Chmielik, E., Simek, K., Huzarski, T., Lubiński, J., Pamuła‐Piłat, J., Pękala, W., Grzybowska, E. A., et al. (2006) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-4-1-28 · Cited by 14
Circulating tumor cells in breast cancer patients
Bystrický, B., & Mego, M. (2015) · Neoplasma · doi:10.4149/neo_2016_003 · Cited by 14
Lee, J., Cho, S.-M., Kim, M. S., Lee, S. H., Chung, Y., & Jung, S. (2017) · Genomics & Informatics · doi:10.5808/gi.2017.15.1.48 · Cited by 9
Majure, M. C., & Logan, A. C. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.11.77 · Cited by 7
Research works printed but not linked: 15
- 10.1200/jco.2015.33.15_suppl.e19082 · doi:10.1200/jco.2015.33.15_suppl.e19082
- 10.1373/clinchem.2014.229476 · doi:10.1373/clinchem.2014.229476
- 10.1196/annals.1448.023 · doi:10.1196/annals.1448.023
- 10.1186/cc4932 · doi:10.1186/cc4932
- Ballester L, 2017, Evaluating circulating tumor DNA from cerebrospinal fluid, Cancer Genet, 34, 214
- 10.1200/jco.2015.33.3_suppl.518 · doi:10.1200/jco.2015.33.3_suppl.518
- 10.1136/esmoopen-2017-000253 · DOI
- Hannafon BN, 2017, The role of metastasis‐associated protein 1 (MTA1) in breast cancer exosome‐mediated intercellular communication, FASEB J, 31, 178.6
- 10.1056/NEJMsr1613680 · doi:10.1056/nejmsr1613680
- 10.3389/fpubh.2014.00087 · doi:10.3389/fpubh.2014.00087
- 10.1007/978-3-319-55661-1_9 · doi:10.1007/978-3-319-55661-1_9
- 10.3233/CBM-2012-0263 · doi:10.3233/cbm-2012-0263
- Tomaszewski JJ, 2014, Heterogeneity and renal mass biopsy: a review of its role and reliability, Cancer Biol Med, 11, 162
- 10.1016/j.jpedsurg.2016.02.066 · doi:10.1016/j.jpedsurg.2016.02.066
- 10.1038/leu.2008.227 · doi:10.1038/leu.2008.227
Cited by
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
Cardoso, F., Paluch-Shimon, S., Senkus, E., Curigliano, G., Aapro, M. S., André, F., Barrios, C. H., Bergh, J., Bhattacharyya, G. S., Biganzoli, L., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.09.010 · Cited by 1,369
“Different technologies are available from single-gene assay by quantitative polymerase chain reaction (qPCR) to whole genome sequencing by next-generation sequencing (NGS).(80,81) Standardisation is a critical point, especially for NGS-based analysis.”
MethodctDNA as a cancer biomarker: A broad overview
Pessoa, L. S., Heringer, M., & Ferrer, V. P. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103109 · Cited by 298
Breast Cancer Screening for Women at Higher-Than-Average Risk: Updated Recommendations From the ACR
Monticciolo, D. L., Newell, M. S., Moy, L., Lee, C. S., & Destounis, S. V. (2023) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2023.04.002 · Cited by 290
Rolfo, C. D., Madison, R. W., Pasquina, L. W., Brown, D. W., Huang, Y., Hughes, J. D., Graf, R. P., Oxnard, G. R., & Husain, H. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-3321 · Cited by 104
Madanat-Harjuoja, L. M., Renfro, L. A., Klega, K., Tornwall, B., Thorner, A. R., Nag, A., Dix, D., Dome, J. S., Diller, L. R., Fernandez, C. V., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.00098 · Cited by 41
Metadata
- Authors
- Alimirzaie, S., Bagherzadeh, M., & Akbari, M. R.
- Venue
- Clinical Genetics
- Publisher
- Wiley
- Published
- 2019-02-27
- Volume
- 95
- Issue
- 6
- Pages
- 643-660
- ISSN
- 0009-9163 (ISSN-L)
- 1399-0004
- OpenAlex
- W2911953146
- Cited by
- 332
- References
- 197
- FWCI
- 11.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.